Fierce Health Payers September 16, 2021
Some safety net hospitals are charging payers a median 3.8 times more than the purchase price for oncology drugs, according to an analysis of hospital price transparency data.
Across a selection of 59 oncology treatment and supportive drugs, the spread between the discounted purchase price and the charged price ranged from a 2.4 times median increase to an 11 times median increase at 340B disproportionate share hospitals, the Community Oncology Alliance (COA) wrote in a report published Tuesday.
The increases in pricing can vary broadly from facility to facility and even within a single hospital, according to the report. Further, 340B hospitals frequently did not list a treatment’s biosimilar and reported charging nearly identical rates to cash-paying patients as they...
Today's Sponsors
Today's Sponsor